NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 

Oncology news

Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project

Archive

Year: 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007


Previous course of cancer screening in the Czech Republic and its implications for treatment availability
2. 9. 2011 Medicína po promoci 4/2011 | More information...

Screening programmes for breast, colorectal and cervical cancer have been initiated in the Czech Republic. These programmes have been shown to decrease population cancer incidence and mortality. Monitoring of screening examinations has been made available in the Czech Republic by pilot project of programmes' information support. It has provided basal data on screening coverage and neoplasia detection.

Hospitals will obtain more data on cancer patients
9. 5. 2011 Zdravotnické noviny | More information...

The Thomayer University Hospital and the University Hospital Na Bulovce have begun to use the software tool I-COP, which has been specifically developed by the Institute of Biostatistics and Analyses at the Masaryk University (Brno, Czech Republic) for cancer centres. The I-COP tool has been designed to combine data from the Czech National Cancer Registry (CNCR) and hospital information systems, which are primarily used to inform health insurance companies about health care provided to patientss.

Funding of the Czech National Cancer Registry has been negotiated over and over again
24. 1. 2011 Medical Tribune | More information...

The Czech National Cancer Registry (CNCR) is a unique database which can be compared to the best cancer registries worldwide with respect to the quality and comprehensiveness of data. It is no exaggeration to say that CNCR is a treasure of the Czech oncology. Maintenance of this registry is a very demanding task, which requires a certain amount of money each year. In the context of total cost of cancer care, this is only a negligible amount of money. Getting those money, however, requires arduous negotiations by the oncologists every year – and this year is no exception.


Back